VVOS Live signals | Maximize Profits with Getagraph.com

BUY 110480 min ago

@ $5.07

Issued: 9 Feb 2024 @ 14:03

Return: -51.48%

Previous signal: Feb 6 - 09:30

Previous signal: Sell

Return: -21.03 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	52 311.00
Average Volume	214 929
Market Cap	6.72M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-1.170 ) 2024-06-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.220
ATR14	$0.0300 (1.22%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-20	Huntsman Ronald Kirk	Buy	14 000	Common Stock
2023-06-16	Huntsman Ronald Kirk	Buy	5 000	Common Stock
2023-06-16	Huntsman Ronald Kirk	Buy	10 000	Common Stock
2023-06-15	Huntsman Ronald Kirk	Buy	21	Common Stock
2023-06-14	Huntsman Ronald Kirk	Buy	10 000	Common Stock

INSIDER POWER
100.00
Last 44 transactions
Buy: 1 747 856 \| Sell: 433 336

Volume Correlation

Long: -0.14 (neutral)

Short: 0.32 (neutral)

Signal:(44.898) Neutral

Vivos Therapeutics, Inc. Correlation

10 Most Positive Correlations
APOP	0.856
COGT	0.851
BBCP	0.835
CNTY	0.834
RMRM	0.833
CHMG	0.824
FFIE	0.82
EXPE	0.815
CHI	0.815
EFSCP	0.814

10 Most Negative Correlations
MMAC	-0.837
BNIXU	-0.826

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vivos Therapeutics, Inc. Correlation - Currency/Commodity

0.71
( moderate )

0.68
( moderate )

0.00
( neutral )

0.65
( moderate )

-0.75
( moderate negative )

-0.57
( weak negative )

Vivos Therapeutics, Inc. Financials

Annual	2023
Revenue:	$13.80M
Gross Profit:	$7.65M (55.43 %)
EPS:	$-11.14

FY	2023
Revenue:	$13.80M
Gross Profit:	$7.65M (55.43 %)
EPS:	$-11.14

FY	2022
Revenue:	$16.02M
Gross Profit:	$10.02M (62.52 %)
EPS:	$-24.62

FY	2021
Revenue:	$16.89M
Gross Profit:	$11.87M (70.31 %)
EPS:	$-1.576

Financial Reports:

No articles found.

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.